|
dt1391
|
71511839
|
Etelcalcetide
|
54
|
ACP5
|
Homo sapiens (human)
|
--
|
Modulator
|
Details
|
|
dt1392
|
71511839
|
Etelcalcetide
|
846
|
CASR
|
Homo sapiens (human)
|
--
|
Agonist
|
Details
|
|
dt1393
|
90311989
|
Bictegravir
|
1576
|
CYP3A4
|
Homo sapiens (human)
|
--
|
Substrate
|
Details
|
|
dt1394
|
90311989
|
Bictegravir
|
54658
|
UGT1A1
|
Homo sapiens (human)
|
--
|
Substrate
|
Details
|
|
dt1395
|
90311989
|
Bictegravir
|
5452
|
POU2F2
|
Homo sapiens (human)
|
--
|
Inhibitor
|
Details
|
|
dt1396
|
90311989
|
Bictegravir
|
55244
|
SLC47A1
|
Homo sapiens (human)
|
--
|
Inhibitor
|
Details
|
|
dt1397
|
90311989
|
Bictegravir
|
--
|
--
|
Severe acute respiratory syndrome coronavirus 2
|
34798775
|
--
|
Details
|
|
dt1398
|
90311989
|
Bictegravir
|
--
|
--
|
Human immunodeficiency virus 1
|
--
|
Human immunodeficiency virus type 1 integrase inhibitor
|
Details
|
|
dt1399
|
90311989
|
Bictegravir
|
8854
|
ALDH1A2
|
Mus musculus (house mouse)
|
34515794
|
Bictegravir results in decreased expression of ALDH1A2 mRNA
|
Details
|
|
dt1400
|
90311989
|
Bictegravir
|
1592
|
CYP26A1
|
Mus musculus (house mouse)
|
34515794
|
Bictegravir results in increased expression of CYP26A1 mRNA
|
Details
|